In collaboration with Dr. Steven Weinman, M.D., Ph.D. (Director of the Liver Center at University of Kansas, Kansas City, Kansas), Cardax evaluated the capacity for a proprietary astaxanthin (ASTX) prodrug...
Read More
By Timothy J. King, Ph.D., Vice President, Research, and A. David Hieber, Ph.D., Associate Director, Biology Type 2 Diabetes Mellitus (T2DM) T2DM is one of the most common age related...
Read More
By Timothy J. King, Ph.D., Vice President, Research Osteoarthritis Background Osteoarthritis (OA) is the most common form of arthritis, a chronic disease of aging. Effective and safe long-term treatment for...
Read More
By Timothy J. King, Ph.D., Vice President, Research The role of oxidative stress and inflammation in liver injury and liver dysfunction as well as the potential for antioxidants to ameliorate...
Read More
By Timothy J. King, Ph.D., Vice President, Research The role of oxidative stress and inflammation in liver injury and liver dysfunction as well as the potential for antioxidants to ameliorate liver disease has been established in both animal models and human trials [Sanchez-Valle et al. 2012; Pacana and Sanyal 2012]. Studies utilizing rodent models of liver disease have also demonstrated the efficacy of astaxanthin (ASTX) in ameliorating liver injury [Kang et al. 2001; Curek et…
By Timothy J. King, Ph.D., Vice President, Research Osteoarthritis (OA) is the most common form of arthritis, a chronic disease of aging. Effective and safe long-term treatment for most OA patients is not available, creating a large unmet medical need. The potential market for OA is very large, where it is estimated that more than 150 million middle class people globally suffer from OA. Symptomatic knee OA alone affects roughly 12% of persons 60 years…
By Timothy J. King, Ph.D., Vice President, Research Studies utilizing rodent models of diabetes, diabetic nephropathy and metabolic dysfunction have shown astaxanthin (ASTX) administration to significantly and positively alter diabetes-associated pathology including dysregulation of glucose levels and insulin sensitivity [1-5].